Patient-reported Outcomes (PROs) in clinical trials in paediatric dentistry

Fiona Gilchrist1, Zoe Marshman2

  • 1Paediatric Dentistry, University of Sheffield, Sheffield, UK.

Insights

Patient-reported outcomes (PROs) offer unique patient insights in clinical trials, but data is often under-reported. This review explores PROs, their benefits, and best practices for their use and reporting in pediatric dentistry research.

Area of Science:

  • Health Services Research
  • Clinical Trials Methodology
  • Patient-Centered Care

Background:

  • Patient-reported outcomes (PROs) are direct patient reports using validated measures (PROMs).
  • PROs are increasingly used in clinical practice and research, offering benefits like reduced bias and enhanced accountability.
  • Despite benefits, PRO data in clinical trials is frequently under-reported, hindering clinical practice adoption.

Purpose of the Study:

  • To define PROs and PROMs and discuss their benefits.
  • To guide the selection of appropriate PROMs for research questions.
  • To address considerations for PRO use in pediatric dentistry and improve future reporting.

Main Methods:

  • Literature review of PROs and PROMs in clinical research.
  • Analysis of benefits and challenges associated with PRO data.
  • Examination of reporting guidelines and case examples in pediatric dentistry.

Main Results:

  • PROs provide valuable patient perspectives often missed by traditional assessments.
  • Choosing the right PROM is crucial for valid and reliable data collection.
  • Standardized reporting and core outcome sets can enhance PRO data utilization.

Conclusions:

  • PROs are essential for patient-centered research, particularly in pediatric dentistry.
  • Addressing under-reporting and improving data interpretation are key for clinical integration.
  • Future research should focus on developing and implementing core outcome sets for consistent PRO reporting.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
104